Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

UCB's CIMZIA(R) (certolizumab Pegol) Approved By The U.S. FDA For Adult Patients Suffering From Moderate To Severe Rheumatoid Arthritis
UCB announced that the U.S. Food and Drug Administration (FDA) approved Cimzia®, the only PEGylated anti-TNF (Tumor Necrosis Factor), for the treatment of adult patients with moderately to severely active rheumatoid arthritis (RA). Cimzia® can be dosed at 400 mg initially and at weeks two and four, followed by 200 mg every other week; for maintenance dosing, 400 mg every four weeks can be considered.

White House Officials Used Twitter, Ashton Kutcher To Promote HIV Testing Day
The White House sought the help of actor Ashton Kutcher to promote National HIV Testing Day on June 27, through his Twitter page, Politico reports. Kutcher has over 2.5 million followers on Twitter, where he recently posted a link to a White House blog post and video commemorating the day. Reid Cherlin, White House assistant press secretary, said, "As technology impacts how and where people are communicating online, we are constantly looking for new ways to engage with the public," adding, "Our efforts to promote National HIV Testing Day included participation from popular users of Twitter, as well as broad social media engagement by agencies across the government." The White House also used Twitter to help connect people to HIV testing sites (Gavin, 6/29).
News of the day
Individuals At Risk For Developing Colon Cancer Identified By Researchers
A new study identifies a group of individuals at increased risk for developing colon cancer and holds the promise for developing new tailored cancer treatments. The study in this week"s issue of the Proceedings of the National Academy of Sciences (PNAS) is by Sanford Markowitz, M.D., Ph.D., the Markowitz-Ingalls Professor of Cancer Genetics at Case Western Reserve University School of Medicine and oncologist at the Ireland Cancer Center of University Hospitals Case Medical Center, and colleagues.
Oncology

Alzheimer's Society Comments On New Alzheimer's Test

A new self administered cognitive screening test for detecting Alzheimer"s disease has been developed by researchers at Addenbrooke"s Hospital in Cambridge, according to a study in bmj.com. Test Your Memory (TYM) is a series of 10 tasks including ability to copy a sentence, semantic knowledge, calculation, verbal fluency and recall ability. The ability to do the test is also scored. The test was completed by 540 healthy individuals (controls) aged 18 to 95 years of age with no history of neurological disease, memory problems or brain injury. A further 139 patients with diagnosed Alzheimer"s or mild cognitive impairment were also tested. The test was compared with the commonly used mini-mental state examination. The TYM detected 93% of patients with Alzheimer"s disease, while the mini-mental state examination detected only 52% of patients. "A test that helps detect dementia sooner in local health care facilities could help more people access vital care and support earlier. However, more research is needed to see if this test works in different settings with different groups of people and establish whether it is more effective than the most sensitive existing tests. One million people will develop dementia in the next 10 years and currently only a third of people with the condition ever receive a diagnosis. We must start investing in research if we are to radically improve the current picture and defeat this devastating condition." Professor Clive Ballard Director of Research Alzheimer"s Society Alzheimer"s Society


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009